Healthcare & Life Sciences
Okapi Sciences
Netherlands
acquiredacquired
acquired
Stage
2014
Founded
1
Investors
About
Okapi Sciences developed a proprietary antiviral platform for pet therapeutics, including antiviral treatment for ocular disease in cats caused by feline herpes virus.
Explore Okapi Sciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.